MedicationsMyBlueDotsStudy finds no elevated risk of thyroid cancer among GLP1-RA users MyBlueDots4 weeks ago01 mins A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased risk of thyroid cancer. Go to Sourcehttps://medicalxpress.com/rss-feed/ Post navigation Previous: Survey shows previous experience affects family planning decisions of people with hereditary dementiaNext: Framework outlines steps for achieving health equity in stroke care